Findings are recent developments in technology and science related to cancer.
June 7, 2019, by NCI Staff Smoldering myeloma is a slow-growing type of multiple myeloma, a form of cancer in which abnormal plasma cells (purple) make too much of a single type […]
JUNE 4, 2019 NFCR WRITER DAVID PERRY BLOG Ask any parent about their child fighting cancer and words like “nightmare” and “helpless” will almost certainly be part of the conversation. Within pediatric cancer medicine, the […]
The latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decline in men, women, and children in the […]
New findings from a study by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, show that U.S. incidence rates for aggressive subtypes of uterine cancer rose […]
“For me, this is one of the great honors of my research career,” says Dr. Ronald DePinho, who in 2009 won the prestigious Szent-Györgyi Prize for Progress in Cancer Research—and who has […]
NFCR Writer David Perry – September 13, 2018 “The trouble with ultrasound is that it doesn’t detect many ovarian cancers early,” says Robert Bast, M.D., Vice President for Translational Research at MD […]
September 5, 2018 A new cancer drug, larotrectinib, has in a very early clinical trial been shown to have a 93% (14/15) effectiveness rate for pediatric cancers; that is to say, for […]
“For the vast majority of cancer—breast, prostate, lung, colon and others—if it is detected early when it is a little lump in that organ and it has not spread, you will live. […]
